Etravirine (ETR)

INDICATIONS

FDA

  • In combination with other ARV agents for treating HIV-1 infection in treatment-experienced pts with PIs-, NRTIs-, and NNRTI-resistant variants.
  • Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).

NON-FDA APPROVED USES

  • Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: July 16, 2023